Pharma, tech giants complained of Canada’s drug pricing system, digital service tax to U.S. trade rep

The board that oversees medicine prices in Canada and levies on big social media and online service platforms appear in submissions to the U.S. Trade Representatives review of 'unfair' foreign trading practices.

In the weeks before U.S. President Donald Trump slapped tariffs on goods from almost every other country, his trade representative sought feedback on 'unfair' trade practices in Canada affecting American firms.Photograph courtesy of Wikimedia Commons

News

BY STEPHEN JEFFERY

April 6, 2025

In the weeks leading up to United States President Donald Trump’s imposition of so-called “reciprocal” tariffs on much of the world, American tech and pharmaceutical giants lobbied their government to take action against Canada’s digital services tax and drug-pricing...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Tuesdays: Innovation & Industry Newsletter

The policies, decisions, and people working on investment and regulation in the industry and innovation realm.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy